SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/β-catenin signaling

Mingzhe Xu, Xiaohang Song, Kudusi, Xiongbing Zu, Minfeng Chen, Wei He, Lin Qi

Open source

DOI
10.1186/s12920-026-02438-y
Published
2026-08-01
Container
BMC Medical Genomics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12920-026-02438-y,
  title = {SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/β-catenin signaling},
  author = {Mingzhe Xu and Xiaohang Song and Kudusi and Xiongbing Zu and Minfeng Chen and Wei He and Lin Qi},
  year = {2026},
  journal = {BMC Medical Genomics},
  doi = {10.1186/s12920-026-02438-y},
  url = {https://doi.org/10.1186/s12920-026-02438-y}
}

RIS

TY  - JOUR
TI  - SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/β-catenin signaling
AU  - Mingzhe Xu
AU  - Xiaohang Song
AU  - Kudusi
AU  - Xiongbing Zu
AU  - Minfeng Chen
AU  - Wei He
AU  - Lin Qi
PY  - 2026
JO  - BMC Medical Genomics
DO  - 10.1186/s12920-026-02438-y
UR  - https://doi.org/10.1186/s12920-026-02438-y
ER  - 

APA

Xu, M., Song, X., Kudusi, Zu, X., Chen, M., He, W., & Qi, L. (2026). SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/β-catenin signaling. BMC Medical Genomics. https://doi.org/10.1186/s12920-026-02438-y

Source records